Stalled at the Gate | Ep. 693

How Biotech’s Capital Markets Became a Traffic Jam

Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was UP +3% and remains red at -8% for the year. This week, we dive into the growing pileup in biotech’s capital markets, where IPOs have vanished, private rounds are shrinking, and even reverse mer…